Ultralife (ULBI) Net Income towards Common Stockholders (2010 - 2026)

Ultralife's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$471000.0 for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 125.07% year-over-year to -$471000.0; the TTM figure through Mar 2026 stood at -$5.8 million (down 1247.2% YoY), while the FY2025 annual figure was -$3.4 million, down 672.19% from the prior year.
• Net Income towards Common Stockholders was -$471000.0 for Q1 2026 at Ultralife, up from -$4.9 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $3.3 million in Q2 2023 to a low of -$5.6 million in Q4 2024.
• Historically, Net Income towards Common Stockholders has averaged -$401470.6 across 5 years, with a median of -$161000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders surged 966.87% in 2024, then slumped 546.95% in 2025.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$3.5 million in 2022, then retreated by 26.54% to -$4.4 million in 2023, then declined by 25.54% to -$5.6 million in 2024, then climbed by 11.85% to -$4.9 million in 2025, then surged by 90.42% to -$471000.0 in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$471000.0 (Q1 2026), -$4.9 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.